|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.027 AUD | -3.57% |
|
-10.00% | -10.00% |
| 05-02 | TrivarX Receives Firm Commitments for AU$2.5 Million Share Issuance; Shares Jump 27% | MT |
| 02-28 | TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Medibio Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was AUD 0.040038 million compared to AUD 0.101656 million a year ago. Net loss was AUD 12.72 million compared to AUD 1.49 million a year ago.
Basic loss per share from continuing operations was AUD 0.0062 compared to AUD 0.001 a year ago. Diluted loss per share from continuing operations was AUD 0.0062 compared to AUD 0.001 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.00% | 6.31M | |
| +16.20% | 79.03B | |
| +8.65% | 8.78B | |
| -16.73% | 4.83B | |
| +48.34% | 4.65B | |
| +2.03% | 3.89B | |
| +18.23% | 2.34B | |
| -26.94% | 2.18B | |
| +16.55% | 2.11B | |
| -36.25% | 2B |
TRIVARX LIMITED 
